Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.290
+0.110 (9.32%)
Nov 4, 2024, 4:00 PM EST - Market closed
Spero Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | 17.46 | 22.81 | -46.42 | -89.76 | -78.28 | -60.93 | Upgrade
|
| Depreciation & Amortization | 0.15 | 0.37 | 0.87 | 0.65 | 0.76 | 0.75 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.18 | Upgrade
|
| Asset Writedown & Restructuring Costs | 5.31 | 5.31 | 0.64 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 0.01 | 0.25 | -0.03 | -0.75 | Upgrade
|
| Stock-Based Compensation | 8.04 | 7.93 | 9.12 | 9.43 | 4.89 | 3.78 | Upgrade
|
| Other Operating Activities | 1.01 | 0.97 | 5.96 | 2.22 | 0.26 | 0.17 | Upgrade
|
| Change in Accounts Receivable | -76.99 | -96.2 | 1.55 | 3.05 | 2.43 | -7.38 | Upgrade
|
| Change in Accounts Payable | 1.39 | 0.76 | -0.48 | -0.05 | -2.98 | 0.56 | Upgrade
|
| Change in Unearned Revenue | 20.32 | 29.01 | 21.89 | 10.64 | - | - | Upgrade
|
| Change in Income Taxes | 0.39 | 0.39 | - | 0.78 | -0.25 | 0.3 | Upgrade
|
| Change in Other Net Operating Assets | 8.57 | -4.33 | -0.87 | -1.56 | -12.67 | 13.3 | Upgrade
|
| Operating Cash Flow | -14.38 | -33 | -7.73 | -64.35 | -85.87 | -50.02 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0.16 | -0.31 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.04 | - | - | Upgrade
|
| Investment in Securities | - | - | 33.81 | 7.63 | 10.63 | 29.84 | Upgrade
|
| Investing Cash Flow | - | - | 33.81 | 7.67 | 10.47 | 29.53 | Upgrade
|
| Issuance of Common Stock | 0.22 | 0.22 | 24.93 | 36.82 | 80.85 | 16.3 | Upgrade
|
| Other Financing Activities | - | - | -54.49 | 47.23 | -0.95 | -0.16 | Upgrade
|
| Financing Cash Flow | 0.22 | 0.22 | -29.55 | 84.05 | 130.88 | 16.14 | Upgrade
|
| Net Cash Flow | -14.16 | -32.77 | -3.48 | 27.38 | 55.48 | -4.35 | Upgrade
|
| Free Cash Flow | -14.38 | -33 | -7.73 | -64.35 | -86.03 | -50.33 | Upgrade
|
| Free Cash Flow Margin | -12.14% | -31.79% | -14.45% | -352.47% | -922.07% | -277.37% | Upgrade
|
| Free Cash Flow Per Share | -0.27 | -0.62 | -0.21 | -2.08 | -3.84 | -2.77 | Upgrade
|
| Cash Income Tax Paid | 2.21 | 2.21 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | 1.48 | -9.9 | -1.08 | -41.44 | -55.16 | -26.47 | Upgrade
|
| Unlevered Free Cash Flow | 1.48 | -9.9 | 0.55 | -40.22 | -55.16 | -26.47 | Upgrade
|
| Change in Net Working Capital | 19.75 | 34.94 | -9.66 | -4.68 | 11.21 | -8.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.